Clinical Trial Update: Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing nedaplatin with cisplatin for nasopharyngeal carcinoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Nedaplatin (nedaplatin)

Snippet

Sponsor: Affiliated Cancer Hospital & Institute of Guangzhou Medical University | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: RECRUITING